Drugs Controller General of India (DCGI)
DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step closer
Earlier, vaccines that had completed clinical studies outside the country were required to carry out 'bridging trials' on Indian people
Zydus Cadila's potential covid drug may begin human clinical trials
India’s 'first' indigenous COVID-19 vaccine candidate Covaxin had also got the nod for human clinical trials recently
2 of 2